William A Weiss Selected Research

Ku 0063794

1/2020	Cooperative Blockade of PKCα and JAK2 Drives Apoptosis in Glioblastoma.
1/2012	Inhibition of PI3K-Akt-mTOR signaling in glioblastoma by mTORC1/2 inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William A Weiss Research Topics

Disease

87	Neoplasms (Cancer) 01/2022 - 08/2002
29	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2005
28	Medulloblastoma 11/2021 - 12/2006
26	Glioma (Gliomas) 11/2021 - 12/2003
25	Neuroblastoma 01/2022 - 09/2003
7	Carcinogenesis 01/2019 - 09/2003
7	Brain Neoplasms (Brain Tumor) 01/2019 - 02/2004
6	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2007
6	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2013
6	Astrocytoma (Pilocytic Astrocytoma) 04/2013 - 01/2005
3	Oligodendroglioma 12/2010 - 04/2003
2	Retinoblastoma (Glioblastoma, Retinal) 01/2014 - 06/2008
1	Neurodevelopmental Disorders 01/2021
1	ATR-X syndrome 11/2019
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 01/2019
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2019 - 09/2003
16	Pharmaceutical PreparationsIBA 01/2019 - 02/2006
14	Phosphotransferases (Kinase)IBA 01/2020 - 08/2002
12	ErbB Receptors (EGF Receptor)IBA 01/2020 - 04/2003
8	epidermal growth factor receptor VIIIIBA 01/2020 - 05/2012
8	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2002
7	Biological ProductsIBA 07/2017 - 02/2004
6	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 03/2009
5	LigandsIBA 01/2022 - 10/2007
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 08/2006
5	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2017 - 08/2006
5	TOR Serine-Threonine KinasesIBA 01/2014 - 01/2009
5	PI103IBA 01/2012 - 05/2006
5	Small Interfering RNA (siRNA)IBA 01/2012 - 01/2005
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2018 - 05/2011
4	Sirolimus (Rapamycin)FDA Link 01/2018 - 09/2007
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2021 - 07/2013
3	NucleotidesIBA 11/2021 - 10/2019
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
3	ChromatinIBA 11/2019 - 01/2017
3	CytokinesIBA 01/2019 - 07/2013
3	LipidsIBA 01/2019 - 07/2012
3	TensinsIBA 01/2019 - 11/2010
3	EnzymesIBA 01/2019 - 05/2006
3	Radiation-Sensitizing AgentsIBA 01/2018 - 07/2011
3	MTOR InhibitorsIBA 01/2018 - 01/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 10/2007
3	N-Myc Proto-Oncogene ProteinIBA 01/2016 - 08/2006
3	PLX 4720IBA 09/2015 - 12/2011
3	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 08/2011
3	3-Iodobenzylguanidine (Iobenguane)IBA 12/2012 - 09/2010
3	dactolisibIBA 01/2012 - 11/2010
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2012 - 12/2006
3	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2007 - 08/2006
3	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 10/2006 - 12/2003
2	Monoclonal AntibodiesIBA 01/2022 - 07/2013
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2016
2	Ku 0063794IBA 01/2020 - 01/2012
2	Lysine (L-Lysine)FDA Link 01/2019 - 03/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2018 - 01/2018
2	gamma-Aminobutyric Acid (GABA)IBA 11/2018 - 11/2014
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018 - 07/2012
2	RapaLink-1IBA 01/2018 - 01/2017
2	Formaldehyde (Formol)FDA Link 01/2016 - 03/2014
2	ParaffinIBA 01/2016 - 03/2014
2	Ion Channels (Ion Channel)IBA 09/2015 - 08/2012
2	Protein Kinases (Protein Kinase)IBA 01/2015 - 08/2002
2	MicroRNAs (MicroRNA)IBA 07/2013 - 06/2008
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 12/2012 - 04/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2012 - 09/2007
2	Histone Deacetylase InhibitorsIBA 07/2011 - 04/2011
2	Vorinostat FDA Link 07/2011 - 04/2011
2	Chloroquine (Aralen)FDA LinkGeneric 05/2011 - 11/2010
2	Caspase 3 (Caspase-3)IBA 11/2008 - 12/2007
1	CalreticulinIBA 01/2022
1	TetraspaninsIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 11/2021
1	AntigensIBA 01/2021
1	Aurora Kinase AIBA 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	monoclonal antibody 806IBA 01/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2020
1	depatuxizumab mafodotinIBA 01/2020
1	PP242IBA 01/2020
1	sapanisertibIBA 01/2020
1	ABT-414IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	BetacellulinIBA 01/2020
1	U1 small nuclear RNAIBA 10/2019
1	Conditioned Culture MediaIBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Aldehyde DehydrogenaseIBA 01/2019
1	Pyruvic Acid (Pyruvate)IBA 01/2019
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2019
1	HhAntag691IBA 01/2019
1	4- (N- methyl- N- (4- (trifluoromethyl)phenyl)sulfamoyl) benzoic acidIBA 01/2019
1	Mitogen-Activated Protein Kinase 3IBA 01/2019

Therapy/Procedure

62	Therapeutics 01/2021 - 10/2002
7	Drug Therapy (Chemotherapy) 11/2016 - 06/2008
3	Immunotherapy 01/2022 - 11/2016
2	Transplantation 01/2019 - 05/2012
1	Ligation 01/2022